Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vittorio Bertele’

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Recenti Progressi in Medicina|January 27, 2007
[False innovations in clinical research]Silvio Garattini, Vittorio Bertele'
Journal of Hepatology|August 12, 2009
Ethics in clinical researchSilvio Garattini, Vittorio Bertele'
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Toward new legislation on drugs in EuropeSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|May 14, 2003
Efficacy, safety and cost of new drugs acting on the central nervous systemSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|September 10, 2003
Efficacy, safety and cost of new cardiovascular drugs: a surveySilvio Garattini, Vittorio Bertele'
International Review of Psychiatry (Abingdon, England)|October 1, 2005
The impact of European regulatory policies on psychotropic drug prescribing patternsSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|November 29, 2017
Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicinesSilvio Garattini, Vittorio Bertele'
The Journal of Ambulatory Care Management|April 9, 2004
A critique to the European regulatory systemVittorio Bertele', Luca Li Bassi
European Journal of Clinical Pharmacology|October 24, 2012
Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EURoberta Joppi, Vittorio Bertele', Silvio Garattini
British Journal of Clinical Pharmacology|February 21, 2006
Orphan drug development is progressing too slowlyRoberta Joppi, Vittorio Bertele, Silvio Garattini
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Recenti Progressi in Medicina|January 27, 2007
[False innovations in clinical research]Silvio Garattini, Vittorio Bertele'
Journal of Hepatology|August 12, 2009
Ethics in clinical researchSilvio Garattini, Vittorio Bertele'
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Toward new legislation on drugs in EuropeSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|May 14, 2003
Efficacy, safety and cost of new drugs acting on the central nervous systemSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|September 10, 2003
Efficacy, safety and cost of new cardiovascular drugs: a surveySilvio Garattini, Vittorio Bertele'
International Review of Psychiatry (Abingdon, England)|October 1, 2005
The impact of European regulatory policies on psychotropic drug prescribing patternsSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|November 29, 2017
Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicinesSilvio Garattini, Vittorio Bertele'
The Journal of Ambulatory Care Management|April 9, 2004
A critique to the European regulatory systemVittorio Bertele', Luca Li Bassi
European Journal of Clinical Pharmacology|October 24, 2012
Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EURoberta Joppi, Vittorio Bertele', Silvio Garattini
British Journal of Clinical Pharmacology|February 21, 2006
Orphan drug development is progressing too slowlyRoberta Joppi, Vittorio Bertele, Silvio Garattini
Pageof 4